Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03679390Terminated
Trial of ketamine in loss of consciousness (LOC) (3 arms), sponsored by National Taiwan University Hospital. Primary endpoint: Increase in dissociation energy in EEG at 1 year. Started Mar 2017; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03679390.